We announced an exclusive licensing collaboration with Bayer for the development and commercialization of our investigational cardiac myosin in Japan for the treatment of patients with obstructive and non-obstructive hypertrophic cardiomyopathy (HCM). https://bit.ly/4eGbgen #HCM
Cytokinetics
Biotechnology Research
South San Francisco, California 27,498 followers
Empowering Muscle Empowering Lives
About us
Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. As a leader in muscle biology and the mechanics of muscle performance, we are developing small molecule drug candidates specifically engineered to impact muscle function and contractility. Proud to be a San Francisco Business Times Best Place to Work in 2021 and 2022, a Great Place to Work-Certified company in 2022 and a part of Fortune's Best Workplaces in the Bay Area in 2022 and Fortune's Best Workplaces in BioPharma in 2022.
- Website
-
http://www.cytokinetics.com
External link for Cytokinetics
- Industry
- Biotechnology Research
- Company size
- 201-500 employees
- Headquarters
- South San Francisco, California
- Type
- Public Company
- Founded
- 1998
- Specialties
- Heart Failure, Amyotrophic Lateral Sclerosis, and Hypertrophic Cardiomyopathy
Locations
-
Primary
Get directions
350 Oyster Point Blvd
South San Francisco, California 94080, US
Employees at Cytokinetics
-
Christopher Brey
Senior Director, Facilities and EHS
-
Brett Pletcher
Chief Legal Officer, Cytokinetics; Life Sciences and Public Company Advisor, Gunderson Dettmer; and Former General Counsel at Gilead Sciences
-
Stefan Engst
Principal Scientist at Cytokinetics
-
Kapil Menghrajani
Biopharmaceutical and Medical Diagnostic Professional
Updates
-
We announced additional data related to our investigational cardiac myosin activator presented at #AHA24. Learn more here: https://bit.ly/40MEuVD #HeartFailure
-
-
Today is our industry theater presentation at #AHA24, “Navigating the Complexities of Hypertrophic Cardiomyopathy: Addressing Delayed Diagnosis, Disease Burden, and Shared Decision-Making.” Learn more here: https://bit.ly/3Um7hvW #HCM
-
-
Today we announced new data related to our investigational cardiac myosin inhibitor presented at #AHA24. Learn more here: https://bit.ly/3AGz7N5 #HCM
-
-
It’s Native American Heritage month, and we’re taking the opportunity to honor the traditions and histories of Native American communities. Today, our colleague Brandy Camps from our Talent Acquisition team shares about her tribe, the Chitimacha Tribe. #NativeAmericanHeritageMonth
-
Join us for a virtual informational session of our internship program. This is a fantastic opportunity for aspiring interns to get a glimpse of our culture at Cytokinetics. Learn about the upcoming opportunities, connect with hiring managers, and discover what a day in the life of an intern looks like in various departments. Please RSVP for our event and an invitation will be sent closer to the day of the event: https://bit.ly/3AN9xWD #Internship #Hiring #Biopharma
-
-
Don’t miss our VP of Medical Affairs, Richey Neuman, MD, MPH, FACP at the Biotechnology Industry Showcase at UC Santa Barbara. As a panelist, Richey will be one of the voices to speak about the biotech industry. Learn more here: https://bit.ly/4hzmSCB
-
-
Today we announced that we will participate in the upcoming Jefferies London Healthcare Conference. Learn more: https://bit.ly/3Z2GHuz
-
-
We are now accepting applications for 2025 summer internships for all departments! At Cytokinetics, we believe in nurturing next-generation talent and providing meaningful opportunities for growth. Our internships offer a chance to work alongside industry professionals, engage in impactful projects, and develop the skills necessary for your future career. This is your chance to kickstart your career and gain hands-on experience in a dynamic and innovative culture. Apply now: https://bit.ly/4628c8Q #Internship #Hiring #Biopharma
-
-
Today we announced the initiation of the Phase 1 clinical study of one our investigational medicines. Learn more: https://bit.ly/40IsfsV #Neuromuscular
-